Spark Therapeutics, Inc. Tech Stack

Spark Therapeutics, Inc. uses 8 technology products and services including OneTrust, Microsoft Access, Mimecast, and more. Explore Spark Therapeutics, Inc.'s tech stack below.

  • OneTrust
    Cookie Compliance
  • Microsoft Access
    Database Management Software
  • Mimecast
    Email Security
  • jQuery Migrate
    Javascript Libraries
  • Websocket
    Miscellaneous
  • Office 365
    Office Suites
  • Amazon Web Services
    Platform As A Service
  • PHP
    Programming Languages

Media & News

Spark Therapeutics, Inc.'s Email Address Formats

Spark Therapeutics, Inc. uses at least 4 format(s):
Spark Therapeutics, Inc. Email FormatsExamplePercentage
first.middle@sparktx.comJohn.Michael@sparktx.com
30%
first.middlelast@sparktx.comJohn.MichaelDoe@sparktx.com
30%
first.middle.last@sparktx.comJohn.Michael.Doe@sparktx.com
20%
first@sparktx.comJohn@sparktx.com
20%

Frequently Asked Questions

Where is Spark Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc.'s main headquarters is located at 3737 Market Street Suite 1300 Philadelphia, PA 19104 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Spark Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Spark Therapeutics, Inc.'s main corporate office by phone at +1-202-729-4089. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Spark Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc. is a publicly traded company; the company's stock symbol is ONCE.

What is Spark Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc.'s official website is sparktx.com and has social profiles on LinkedIn.

How much revenue does Spark Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of March 2024, Spark Therapeutics, Inc.'s annual revenue reached $750M.

What is Spark Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc.'s SIC code is 2836 - Biological Products, Except Diagnostic Substances NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Spark Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2024, Spark Therapeutics, Inc. has approximately 1K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: R. P.Chief People Officer: J. F.Chief Medical And Product Strategy Officer: G. L.. Explore Spark Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Spark Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Spark Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc.'s tech stack includes OneTrustMicrosoft AccessMimecastjQuery MigrateWebsocketOffice 365Amazon Web ServicesPHP.

What is Spark Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc.'s email format typically follows the pattern of first.middle@sparktx.com. Find more Spark Therapeutics, Inc. email formats with LeadIQ.

How much funding has Spark Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of March 2024, Spark Therapeutics, Inc. has raised $380M in funding. The last funding round occurred on Aug 03, 2017.

When was Spark Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc. was founded in 2013.
Spark Therapeutics, Inc.

Spark Therapeutics, Inc.

Biotechnology ResearchPennsylvania, United States501-1000 Employees

At Spark® Therapeutics, we believe in a world where no life is limited by disease.   

We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our mission is to unlock the power of gene therapy to accelerate healthcare transformation.  
 
Since our founding, we have been committed to bringing a wide range of expertise to build a fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver, such as hemophilia. We are seeking talented individuals with diverse experiences, abilities and interests who have the curiosity, courage and drive to reimagine a new health care paradigm.  
 
Join us on a journey through uncharted territory – seeking to bring gene therapy to people worldwide. The resilience of the people we serve is our inspiration to break barriers, as we strive to turn genes into medicine. Spark is a member of the Roche Group.  
 
Know that working at Spark® Therapeutics is not just another job; it is a once-in-a-lifetime opportunity. We embrace the challenges before us and the uncertainty inherent in them. Ultimately, we are working to create a world where no life is limited by disease. To learn more about Spark and our open positions, visit www.sparktx.com. You can also find us on Twitter at @Spark_tx. 

Spark’s social media sites are monitored from Monday to Friday during normal business hours. Questions or concerns should be directed here: https://sparktx.com/contact-us/.

Section iconCompany Overview

Headquarters
3737 Market Street Suite 1300 Philadelphia, PA 19104 US
Phone number
+1-202-729-4089
SIC Code
2836 - Biological Products, Except Diagnostic Substances
Stock Symbol
ONCE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
501-1000

Section iconFunding & Financials

  • $380M

    Spark Therapeutics, Inc. has raised a total of $380M of funding over 5 rounds. Their latest funding round was raised on Aug 03, 2017.

  • $100M$1B

    Spark Therapeutics, Inc.'s revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $380M

    Spark Therapeutics, Inc. has raised a total of $380M of funding over 5 rounds. Their latest funding round was raised on Aug 03, 2017.

  • $100M$1B

    Spark Therapeutics, Inc.'s revenue is in the range of $100M$1B

© LeadIQ, Inc. All rights reserved.